Exactus, Inc. is a healthcare company. The Company is focused on manufacturing hemp derived Cannabidiol (CBD) products. It sells its CBD products through its Exactus brand and white label products to third-party resellers. It is also engaged in producing industrial hemp from farms in Oregon. Its products product line includes hemp flower, pre-rolled hemp flower, topicals, tinctures and concentrates. It also offers point-of-care diagnostic tools to analyze biometric markers in a drop of blood. Its FibriLyzer product provides solution to assess the fibrinolytic status of patients in a broad range of applications, including surgery, trauma, orthopedics, heart, stroke and chronic coronary disease management. Its MatriLyzer product detects the initial occurrence or the recurrence of cancer during routine office visits.

Employees

Sector

Pharmaceuticals

More about the company

Nov. 18	Panacea Life Sciences Holdings and Benivita Inc. Launch Benivita PLSH	CI
24-05-06	Panacea Life Sciences Holdings, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024	CI

Market Cap	519K 450K 421K 384K 722K 49.5M 734K 4.96M 1.94M 24.79M 1.95M 1.91M 82.65M	P/E 2022	-0.11x	P/E 2023	-0.31x
Enterprise Value	22.05M 19.1M 17.9M 16.33M 30.69M 2.1B 31.16M 211M 82.29M 1.05B 82.78M 80.98M 3.51B	EV / Sales 2022	11.6x	EV / Sales 2023	10.1x
Free-Float	-	Yield 2022 *	-	Yield 2023	-

Nov. 18	Panacea Life Sciences Holdings and Benivita Inc. Launch Benivita PLSH	CI
24-05-06	Panacea Life Sciences Holdings, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024	CI
24-04-01	Panacea Life Sciences Holdings, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	CI
24-03-31	Panacea Life Sciences Holdings, Inc. Auditor Raises 'Going Concern' Doubt	CI
23-11-14	Panacea Life Sciences Holdings, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	CI
23-10-04	Panacea Life Sciences Holdings, Inc. completed the acquisition of N7 Enterprises, Inc.	CI
23-10-01	Panacea Life Sciences Holdings, Inc. entered into an Asset Purchase Agreement to acquire PÜR LIFE Medical, Inc.	CI
23-09-29	Panacea Life Sciences Holdings, Inc. completed the acquisition of Nitro Kava & Kratom from Gary Wilder, Lizard Juice, LLC, N7 Enterprises, Inc. and New Age Distribution Corp. for $7.8 million.	CI
23-08-15	Panacea Life Sciences Holdings, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023	CI
23-08-01	Panacea Life Sciences Holdings, Inc. entered into a non-binding LOI to acquire Sierra Sages Herbs, LLC and Halucenex Life Sciences Inc. for $20 million.	CI
23-07-09	Panacea Life Sciences Holdings, Inc. agreed to acquire Nitro Kava & Kratom.	CI
23-07-09	Panacea Life Sciences Holdings, Inc. entered into agreements acquire 8 Retail Locations in the Tampa, Florida.	CI
23-06-15	Panacea Life Sciences Holdings, Inc. Distribution Division Signs Exclusive Distribution Agreement with QR Joy to Distribute U.S. Top Fume Disposable Vape Devices in the U.K	CI

Nov. 18	Panacea Life Sciences Holdings (OTCID: PLSH) and Benivita Inc. Launch Benivita PLSH -- a New Era in Direct-to-Consumer Virtual Benefits	PR
24-05-16	Panacea Life Sciences and Sky Wellness Enter Agreement for Licensing, Marketing, Supply and Development of Sky Wellness CBD Products	AQ
24-05-16	Panacea Life Sciences : and Sky Wellness Enter Agreement for Licensing, Marketing, Supply and Development of Sky Wellness CBD Products - Form 8-K	PU
23-10-05	Panacea Life Sciences Holdings, Inc. Completes Acquisition of N7 Enterprises With Eight Natural Health and Wellness Retail and One Distribution Center Locations in the Tampa, Florida area	AQ
23-10-02	Panacea Life Sciences Holdings, Inc. Continues Growth Trajectory with Acquisition of the PÜR LIFE Medical Franchise	AQ

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Change	5-day change	1-year change	3-year change	Capi.($)
ELI LILLY AND COMPANY	+0.43%	+4.31%	+90.84%	+130.99%	1,088B
JOHNSON & JOHNSON	+0.41%	+1.27%	+50.98%	+50.05%	629B
ABBVIE INC.	-0.53%	+1.04%	+25.23%	+63.46%	440B
ROCHE HOLDING AG	-0.41%	-0.22%	+45.73%	+37.40%	359B
NOVARTIS AG	-0.22%	-1.02%	+27.05%	+36.27%	291B
ASTRAZENECA PLC	-0.16%	-1.47%	+2.03%	+5.06%	245B
AMGEN INC.	+0.45%	+2.05%	+46.04%	+58.54%	225B
NOVO NORDISK A/S	-1.04%	+0.75%	-9.24%	-52.24%	204B
GILEAD SCIENCES, INC.	+0.07%	+3.12%	+13.21%	+69.84%	168B
Average	+0.14%	+1.27%	+32.43%	+44.37%	405.47B
Weighted average by Cap.	+0.36%	+1.93%	+48.62%	+66.13%

Exactus Inc Stock OTC Bulletin Board

Stocks

Pharmaceuticals

Valuation: Exactus Inc

Latest news : Exactus Inc

Press Releases: Exactus Inc

Other Pharmaceuticals

Financials

Company Profile

	2022	2023
Net sales	1.63M 1.41M 1.32M 1.2M 2.26M 155M 2.3M 15.53M 6.07M 77.7M 6.11M 5.98M 259M	2.38M 2.07M 1.94M 1.77M 3.32M 227M 3.37M 22.77M 8.9M 114M 8.95M 8.76M 380M
Net income	-9.14M -7.92M -7.42M -6.77M -12.73M -872M -12.92M -87.29M -34.12M -437M -34.33M -33.58M -1.46B	-8.02M -6.94M -6.51M -5.93M -11.16M -764M -11.33M -76.53M -29.91M -383M -30.09M -29.44M -1.28B
Net Debt	17.85M 15.47M 14.49M 13.22M 24.85M 1.7B 25.23M 170M 66.63M 853M 67.03M 65.58M 2.84B	21.53M 18.65M 17.48M 15.94M 29.97M 2.05B 30.43M 206M 80.35M 1.03B 80.83M 79.08M 3.43B

End-of-day quote OTC Bulletin Board
- ^USD	-